144 related articles for article (PubMed ID: 35195716)
1. Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Certan M; Garcia Garrido HM; Wong G; Heijmans J; Grobusch MP; Goorhuis A
Clin Infect Dis; 2022 Sep; 75(6):1046-1053. PubMed ID: 35195716
[TBL] [Abstract][Full Text] [Related]
2. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.
Heo JY; Seo YB; Choi WS; Lee J; Yoon JG; Lee SN; Choi MJ; Noh JY; Ahn JY; Jeong HW; Cheong HJ; Kim WJ; Lee HY; Song JY
PLoS One; 2018; 13(3):e0194598. PubMed ID: 29596444
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
4. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
7. Burden of community-acquired pneumonia in North American adults.
File TM; Marrie TJ
Postgrad Med; 2010 Mar; 122(2):130-41. PubMed ID: 20203464
[TBL] [Abstract][Full Text] [Related]
8. Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.
Krueger P; St Amant O; Loeb M
BMC Geriatr; 2010 Jun; 10():44. PubMed ID: 20591180
[TBL] [Abstract][Full Text] [Related]
9. Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU.
Belkhouja K; Ben Romdhane K; Ghariani A; Hammami A; M'hiri E; Slim-Saidi L; Ben Khelil J; Besbes M
J Infect Chemother; 2012 Jun; 18(3):324-31. PubMed ID: 22045164
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
Garcia Garrido HM; Mak AMR; Wit FWNM; Wong GWM; Knol MJ; Vollaard A; Tanck MWT; Van Der Ende A; Grobusch MP; Goorhuis A
Clin Infect Dis; 2020 Jun; 71(1):41-50. PubMed ID: 31634398
[TBL] [Abstract][Full Text] [Related]
11. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan.
Naito S; Tanaka J; Nagashima K; Chang B; Hishiki H; Takahashi Y; Oikawa J; Nagasawa K; Shimojo N; Ishiwada N
Epidemiol Infect; 2016 Feb; 144(3):494-506. PubMed ID: 26122538
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.
Di Pasquale MF; Sotgiu G; Gramegna A; Radovanovic D; Terraneo S; Reyes LF; Rupp J; González Del Castillo J; Blasi F; Aliberti S; Restrepo MI;
Clin Infect Dis; 2019 Apr; 68(9):1482-1493. PubMed ID: 31222287
[TBL] [Abstract][Full Text] [Related]
13. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
Jimenez Trujillo I; Lopez de Andres A; Hernandez-Barrera V; Martinez-Huedo MA; de Miguel-Diez J; Jimenez-Garcia R
Vaccine; 2017 Jun; 35(30):3733-3740. PubMed ID: 28558982
[TBL] [Abstract][Full Text] [Related]
15. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).
Gil-Prieto R; García-García L; Alvaro-Meca A; Méndez C; García A; de Miguel AG
Vaccine; 2011 Jan; 29(3):412-6. PubMed ID: 21111780
[TBL] [Abstract][Full Text] [Related]
16. Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005-2018: a Canadian Immunisation Research Network (CIRN) study.
Nasreen S; Wang J; Sadarangani M; Kwong JC; Quach C; Crowcroft NS; Wilson SE; McGeer A; Morris SK; Kellner JD; Sander B; Kus JV; Hoang L; Marra F; Fadel SA
BMJ Open Respir Res; 2022 Jun; 9(1):. PubMed ID: 35764362
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
[TBL] [Abstract][Full Text] [Related]
18. Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study.
Chiou WY; Hung SK; Lai CL; Lin HY; Su YC; Chen YC; Shen BJ; Chen LC; Tsai SJ; Lee MS; Li CY
Medicine (Baltimore); 2015 Jul; 94(26):e1022. PubMed ID: 26131806
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
[TBL] [Abstract][Full Text] [Related]
20. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
